vs
APOGEE ENTERPRISES, INC.（APOG）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是APOGEE ENTERPRISES, INC.的1.8倍（$622.0M vs $351.4M），Royalty Pharma plc净利率更高（34.4% vs 4.7%，领先29.7%），Royalty Pharma plc同比增速更快（4.8% vs 1.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 2.9%）
Apogee Enterprises是一家美国音频设备制造商，主营音频接口、模数与数模转换器、USB及iOS麦克风，同时还开发音频制作相关软件，产品广泛服务于专业录音、音乐创作等音频领域，在全球音频行业拥有较高的认可度。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
APOG vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$351.4M
营收增速更快
RPRX
高出3.2%
1.6%
净利率更高
RPRX
高出29.7%
4.7%
两年增速更快
RPRX
近两年复合增速
2.9%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $351.4M | $622.0M |
| 净利润 | $16.6M | $214.2M |
| 毛利率 | 22.4% | — |
| 营业利润率 | 7.3% | 62.4% |
| 净利率 | 4.7% | 34.4% |
| 营收同比 | 1.6% | 4.8% |
| 净利润同比 | 568.8% | 2.9% |
| 每股收益（稀释后） | $0.78 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APOGRPRX
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $622.0M | ||
| Q3 25 | $358.2M | $609.3M | ||
| Q2 25 | $346.6M | $578.7M | ||
| Q1 25 | $345.7M | $568.2M | ||
| Q4 24 | $341.3M | $593.6M | ||
| Q3 24 | $342.4M | $564.7M | ||
| Q2 24 | $331.5M | $537.3M |
净利润APOGRPRX
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $214.2M | ||
| Q3 25 | $23.6M | $288.2M | ||
| Q2 25 | $-2.7M | $30.2M | ||
| Q1 25 | $2.5M | $238.3M | ||
| Q4 24 | $21.0M | $208.2M | ||
| Q3 24 | $30.6M | $544.0M | ||
| Q2 24 | $31.0M | $102.0M |
毛利率APOGRPRX
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 29.8% | — |
营业利润率APOGRPRX
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | 62.4% | ||
| Q3 25 | 7.5% | 70.1% | ||
| Q2 25 | 2.0% | 36.3% | ||
| Q1 25 | 1.8% | 94.0% | ||
| Q4 24 | 8.4% | 60.9% | ||
| Q3 24 | 12.3% | — | ||
| Q2 24 | 12.5% | 50.2% |
净利率APOGRPRX
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | 34.4% | ||
| Q3 25 | 6.6% | 47.3% | ||
| Q2 25 | -0.8% | 5.2% | ||
| Q1 25 | 0.7% | 41.9% | ||
| Q4 24 | 6.1% | 35.1% | ||
| Q3 24 | 8.9% | 96.3% | ||
| Q2 24 | 9.4% | 19.0% |
每股收益（稀释后）APOGRPRX
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $0.49 | ||
| Q3 25 | $1.10 | $0.67 | ||
| Q2 25 | $-0.13 | $0.07 | ||
| Q1 25 | $0.12 | $0.55 | ||
| Q4 24 | $0.96 | $0.46 | ||
| Q3 24 | $1.40 | $1.21 | ||
| Q2 24 | $1.41 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $618.7M |
| 总债务越低越好 | $232.3M | $9.0B |
| 股东权益账面价值 | $511.8M | $9.7B |
| 总资产 | $1.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资APOGRPRX
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $618.7M | ||
| Q3 25 | $39.5M | $938.9M | ||
| Q2 25 | $32.8M | $631.9M | ||
| Q1 25 | $41.4M | $1.1B | ||
| Q4 24 | $43.9M | $929.0M | ||
| Q3 24 | $51.0M | $950.1M | ||
| Q2 24 | $30.4M | $1.8B |
总债务APOGRPRX
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | $285.0M | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益APOGRPRX
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $9.7B | ||
| Q3 25 | $500.2M | $9.6B | ||
| Q2 25 | $481.8M | $9.5B | ||
| Q1 25 | $487.9M | $9.8B | ||
| Q4 24 | $522.1M | $10.3B | ||
| Q3 24 | $506.4M | $10.3B | ||
| Q2 24 | $480.0M | $9.8B |
总资产APOGRPRX
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $19.6B | ||
| Q3 25 | $1.2B | $19.3B | ||
| Q2 25 | $1.2B | $18.3B | ||
| Q1 25 | $1.2B | $17.6B | ||
| Q4 24 | $1.2B | $18.2B | ||
| Q3 24 | $917.1M | $18.0B | ||
| Q2 24 | $889.0M | $17.7B |
负债/权益比APOGRPRX
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | 0.58× | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $122.5M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 7.8% | — |
| 现金转化率经营现金流/净利润 | 7.37× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流APOGRPRX
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $827.1M | ||
| Q3 25 | $57.1M | $702.6M | ||
| Q2 25 | $-19.8M | $364.0M | ||
| Q1 25 | $30.0M | $596.1M | ||
| Q4 24 | $31.0M | $742.5M | ||
| Q3 24 | $58.7M | $703.6M | ||
| Q2 24 | $5.5M | $658.2M |
自由现金流APOGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $52.4M | — | ||
| Q2 25 | $-26.9M | — | ||
| Q1 25 | $19.1M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $50.2M | — | ||
| Q2 24 | $-1.8M | — |
自由现金流率APOGRPRX
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 14.6% | — | ||
| Q2 25 | -7.8% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 14.7% | — | ||
| Q2 24 | -0.5% | — |
资本支出强度APOGRPRX
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.2% | — |
现金转化率APOGRPRX
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | 3.86× | ||
| Q3 25 | 2.41× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 12.08× | 2.50× | ||
| Q4 24 | 1.48× | 3.57× | ||
| Q3 24 | 1.92× | 1.29× | ||
| Q2 24 | 0.18× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
